EC Number   |
Activating Compound |
Reference |
|---|
   2.3.1.43 | 3-{[5-(ethylsulfanyl)-1,3,4-thiadiazol-2-yl]sulfanyl}pyrazine-2-carbonitrile |
compound activates plasma LCAT from multiple species in vitro |
720368 |
| 2.3.1.43 | albumin |
phospholipase activity is dependent on |
486990 |
| 2.3.1.43 | albumin |
stimulates |
486977 |
| 2.3.1.43 | alpha-linolenic acid |
a moderate dietary intake of myristic acid (1.8% total energy) and alpha-linolenic acid (0.9% total energy) increases LCAT activity |
688771 |
| 2.3.1.43 | antibody 27C3 |
antibody 27C3 binds to and substantially enhances the activity of the enzyme |
757166 |
| 2.3.1.43 | antibody 27C3 |
antibody 27C3 binds to and substantially enhances the activity of the enzyme. 24 h after dosing 27C3, a 2.3fold increase of the serum enzyme enzyme activity is observed, followed by a steady elevation of enzyme activity that is sustained for about 20 days before gradually returning to baseline levels |
757166 |
| 2.3.1.43 | apolipoprotein A-I |
- |
486977, 486995, 487010, 487028, 661231, 663302, 688067, 702466, 703246, 703838, 735428 |
| 2.3.1.43 | apolipoprotein A-I |
a disulfide-linked apoprotein dimer is less effective as activator than apo A-I |
487017 |
| 2.3.1.43 | apolipoprotein A-I |
absolute requirement with phosphatidylcholine-cholesterol vesicles as a substrate |
486978, 486981, 487007 |
| 2.3.1.43 | apolipoprotein A-I |
activates recombinant enzymes |
487014 |
